Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Atypical Manifestation of X-linked Agammaglobulinemia - the Importance of Genetic Testing

A. Markocsy, D. Kapustová, A. Čereš, E. Froňkova, M. Jeseňák

. 2024 ; 67 (2) : 60-63. [pub] -

Language English Country Czech Republic

Document type Journal Article, Case Reports

X-linked agammaglobulinemia (XLA) was one of the first inborn errors of immunity to be described. It is caused by pathogenic variants in the gene for Bruton tyrosine kinase (BTK), which has important functions in B cell development and maturation. Recurrent bacterial infections in the first two years of life and hypogammaglobulinemia with absent B cells in male patients are the most common symptoms. A four-month-old male patient underwent surgical removal of urachus persistens complicated with recurrent scar abscesses. Hypogammaglobulinemia (IgG, IgA, and IgM), low phagocytic activity, mild neutropenia, and a normal percentage of B cells were observed in the patient's immune laboratory profile. Over time, he suffered recurrent respiratory infections (otitis media and rhinosinusitis) and developed B cell depletion, but interestingly, this was with a normalisation of IgG and IgA levels along with undetectable IgM. Molecular-genetic testing confirmed the presence of the pathogenic variant c.1843C>T in the BTK gene, which is associated with a milder phenotype of XLA. Molecular-genetic testing uncovers the variability of clinical and laboratory features of apparently well-known inherited disorders. Patients with mild "leaky" XLA may have normal levels of non-functional or oligoclonal immunoglobulins.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24020963
003      
CZ-PrNML
005      
20250513151356.0
007      
ta
008      
241105s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2024.21 $2 doi
035    __
$a (PubMed)39434672
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Markocsy, Adam $u Centre for Primary Immunodeficiencies, Department of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia $7 xx0265337
245    10
$a Atypical Manifestation of X-linked Agammaglobulinemia - the Importance of Genetic Testing / $c A. Markocsy, D. Kapustová, A. Čereš, E. Froňkova, M. Jeseňák
520    9_
$a X-linked agammaglobulinemia (XLA) was one of the first inborn errors of immunity to be described. It is caused by pathogenic variants in the gene for Bruton tyrosine kinase (BTK), which has important functions in B cell development and maturation. Recurrent bacterial infections in the first two years of life and hypogammaglobulinemia with absent B cells in male patients are the most common symptoms. A four-month-old male patient underwent surgical removal of urachus persistens complicated with recurrent scar abscesses. Hypogammaglobulinemia (IgG, IgA, and IgM), low phagocytic activity, mild neutropenia, and a normal percentage of B cells were observed in the patient's immune laboratory profile. Over time, he suffered recurrent respiratory infections (otitis media and rhinosinusitis) and developed B cell depletion, but interestingly, this was with a normalisation of IgG and IgA levels along with undetectable IgM. Molecular-genetic testing confirmed the presence of the pathogenic variant c.1843C>T in the BTK gene, which is associated with a milder phenotype of XLA. Molecular-genetic testing uncovers the variability of clinical and laboratory features of apparently well-known inherited disorders. Patients with mild "leaky" XLA may have normal levels of non-functional or oligoclonal immunoglobulins.
650    _2
$a lidé $7 D006801
650    12
$a agamaglobulinemie $x genetika $x diagnóza $7 D000361
650    _2
$a mužské pohlaví $7 D008297
650    12
$a genetické nemoci vázané na chromozom X $x genetika $x diagnóza $7 D040181
650    12
$a proteinkinasa BTK $x genetika $7 D000077329
650    12
$a genetické testování $7 D005820
650    _2
$a kojenec $7 D007223
655    _2
$a časopisecké články $7 D016428
655    _2
$a kazuistiky $7 D002363
700    1_
$a Kapustová, Daniela, $d 1995- $u Centre for Primary Immunodeficiencies, Department of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia $7 xx0278236
700    1_
$a Čereš, Andrej $u Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia $7 xx0331991
700    1_
$a Froňková, Eva, $d 1977- $u CLIP Laboratory centre, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0105058
700    1_
$a Jeseňák, Miloš, $d 1980- $u Centre for Primary Immunodeficiencies, Department of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia. jesenak@gmail.com $u Centre for Primary Immunodeficiencies, Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia. jesenak@gmail.com $u Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia. jesenak@gmail.com $7 xx0104191
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 67, č. 2 (2024), s. 60-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39434672 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20241105 $b ABA008
991    __
$a 20250513151359 $b ABA008
999    __
$a ok $b bmc $g 2316506 $s 1232953
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 67 $c 2 $d 60-63 $e - $i 1805-9694 $m Acta medica (Hradec Kralove) $n Acta Medica (Hradec Kralove) $x MED00010947
LZP    __
$b NLK124 $a Pubmed-20241105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...